Results 121 to 130 of about 863 (134)
Some of the next articles are maybe not open access.

The putative role of the relaxin-3/RXFP3 system in clinical depression and anxiety: A systematic literature review

Neuroscience and Biobehavioral Reviews, 2021
Gavin S. Dawe   +2 more
exaly  

Top bar navigation

Frontiers in Neuroscience, 2021
Laura Gray   +2 more
exaly  

Inhibition of oxytocin and vasopressin neuron activity in rat hypothalamic paraventricular nucleus by relaxin-3-RXFP3 signalling.

Journal of Physiology, 2017
Tomasz Blasiak, Alan Kania, Anna Blasiak
exaly  

Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135)

European Journal of Pharmacology, 2008
John Atack   +2 more
exaly  

Central injection of relaxin-3 receptor (RXFP3) antagonist peptides reduces motivated food seeking and consumption in C57BL/6J mice

Behavioural Brain Research, 2014
John D Wade   +2 more
exaly  

Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23–27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3)

British Journal of Pharmacology, 2014
John D Wade, Roger J. Summers
exaly  

Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer’s disease patients

Psychopharmacology, 2015
Gavin S. Dawe   +2 more
exaly  

Synthesis and pharmacological characterization of a europium-labelled single-chain antagonist for binding studies of the relaxin-3 receptor RXFP3

Amino Acids, 2015
Ross Bathgate   +2 more
exaly  

People also looked at

Frontiers in Endocrinology, 2013
Ross Bathgate   +2 more
exaly  

Metabolic and Neuroendocrine Responses to RXFP3 Modulation in the Central Nervous System

Annals of the New York Academy of Sciences, 2009
Andrew L Gundlach   +2 more
exaly  
relaxin-3
cervical cancer
medicine
dna methylation
neuropeptide
hippocampus
previous   11  12  13  14  

Home - About - Disclaimer - Privacy